SRT-1720 (Q7392863)
Jump to navigation
Jump to search
SRT1720 is an experimental drug intended as a small-molecule activator of the sirtuin subtype SIRT
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SRT-1720 |
SRT1720 is an experimental drug intended as a small-molecule activator of the sirtuin subtype SIRT |
Statements
469.168±0 dalton
1 reference
925434-55-5 (English)
19 October 2016
C₂₅H₂₃N₇OS
1 reference
925434-55-5 (English)
19 October 2016
C1CN(CCN1)CC2=CSC3=NC(=CN23)C4=CC=CC=C4NC(=O)C5=NC6=CC=CC=C6N=C5
1 reference
925434-55-5 (English)
19 October 2016
1 reference
SRT-1720
0 references
Identifiers
1 reference
925434-55-5 (English)
19 October 2016
1 reference
925434-55-5 (English)
19 October 2016
1 reference
N-{2-[3-(1-Piperazinylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}-2-quinoxalinecarboxamide (English)
19 October 2016
2 references
925434-55-5 (English)
19 October 2016
1 reference
CHEMBL257991 (English)
19 October 2016
1 reference
SRT1720 (English)
19 October 2016
1 reference
4BN5 (English)
19 October 2016
Sitelinks
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(1 entry)
- commonswiki Category:SRT-1720